Results 51 to 60 of about 19,645 (254)

Differential binding patterns of anti-sulfatide antibodies to glial membranes [PDF]

open access: yes, 2018
Sulfatide is a major glycosphingolipid in myelin and a target for autoantibodies in autoimmune neuropathies. However neuropathy disease models have not been widely established, in part because currently available monoclonal antibodies to sulfatide may ...
Barrie, Jennifer A.   +8 more
core   +1 more source

Regulation of Transmembrane Signaling by Ganglioside GM1 : [PDF]

open access: yesJournal of Neurochemistry, 1999
Abstract : Interaction of antibodies to ganglioside GM1 with Neuro2a cells was studied to investigate the role of GM1 in cell signaling. Binding of anti‐GM1 to Neuro2a cells induced the formation of 3H‐inositol phosphates (3H‐IPs) and elevated the intracellular Ca2+ concentration [Ca2+]i.
B, Ravichandra, P G, Joshi
openaire   +2 more sources

Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice

open access: yesJournal of Lipid Research, 2005
II3NeuAc-GgOse4Cer (GM1) gangliosidosis is an incurable lysosomal storage disease caused by a deficiency in acid β-galactosidase (β-gal), resulting in the accumulation of ganglioside GM1 and its asialo derivative GgOse4Cer (GA1) in the central nervous ...
J.L. Kasperzyk   +4 more
doaj   +1 more source

Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy [PDF]

open access: yes, 2017
Impairment of peripheral nerve function is frequent in neurometabolic diseases, but mechanistically not well understood. Here, we report a novel disease mechanism and the finding that glial lipid metabolism is critical for axon function, independent of ...
Asadollahi, Ebrahim   +17 more
core   +3 more sources

Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis)

open access: yesJournal of Lipid Research, 1967
The carbohydrate composition was determined for ceramide hexosides isolated from brains of patients with Tay-Sachs disease and generalized gangliosidosis (hereby named GM1-gangliosidosis).Gray matter of patients with each disease showed a characteristic ...
Kunihiko Suzuki, Gloria C. Chen
doaj   +1 more source

Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer [PDF]

open access: yes, 2018
In this study, we report how the cholera toxin (CT) A subunit (CTA), the enzyme moiety responsible for signaling alteration in host cells, enters the exosomal pathway, secretes extracellularly, transmits itself to a cell population.
Boussadia, Zaira   +11 more
core   +1 more source

Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration. [PDF]

open access: yesPLoS ONE, 2011
Converging evidence shows that GD3 ganglioside is a critical effector in a number of apoptotic pathways, and GM1 ganglioside has neuroprotective and noötropic properties.
Anandh Dhanushkodi, Michael P McDonald
doaj   +1 more source

Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches [PDF]

open access: yes, 2013
Altered networks of gene regulation underlie many pathologies, including cancer. There are several proteins in cancer cells that are turned either on or off, which dramatically alters the metabolism and the overall activity of the cell, with the complex ...
Daniotti, Jose Luis   +4 more
core   +2 more sources

GM1 Gangliosidosis: Mechanisms and Management

open access: yesThe Application of Clinical Genetics, 2021
Allisandra K Rha,1 Anne S Maguire,1,2 Douglas R Martin1,2 1Scott-Ritchey Research Center, Auburn University, Auburn, AL, 36849, USA; 2Department of Anatomy, Physiology, and Pharmacology, Auburn University College of Veterinary Medicine, Auburn, AL, 36849,
Rha AK, Maguire AS, Martin DR
doaj  

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP

open access: yesBiomedicines, 2023
Past evidence has shown that the exogenous administration of GM1 ganglioside slowed neuronal death in preclinical models of Parkinson’s disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons: however ...
Maria Fazzari   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy